Selective genetic advantages for users of thiazide diuretics. Is there a case for the 460Trp variant of α-adducin?

Journal of Hypertension

Volumn 27, Issue 1, 2009, Pages 24-27

  De Buyzere, Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADDUCIN; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; THIAZIDE DIURETIC AGENT; ADDUCIN; CALMODULIN BINDING PROTEIN;

CARDIOVASCULAR RISK; EDITORIAL; GENE INTERACTION; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; OUTCOME ASSESSMENT; PHARMACOGENETICS; PRIORITY JOURNAL; SALT INTAKE; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; ANIMAL; CORONARY ARTERY DISEASE; GENETICS; NOTE;

ANIMALS; CALMODULIN-BINDING PROTEINS; CORONARY DISEASE; HUMANS; HYPERTENSION; POLYMORPHISM, SINGLE NUCLEOTIDE; SODIUM CHLORIDE SYMPORTER INHIBITORS; STROKE;

EID: 58849127829     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831cf01b     Document Type: Editorial

References (27)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
2. Turnbull F. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet 2003; 362:1527-1535.
3. Staessen J, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantative overview updated until 1 March 2003. J Hypertens 2003; 21:1055-1076.
4. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349:1353-1357.
5. Bianchi G. Genetic variations of tubular sodium reabsorption leading to 'primary' hypertension: from gene polymorphism to clinical symptoms. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1536-R1549
6. Manunta P, Burnier M, D'Amico M, Buzzi L, Maillard M, Barlissina C, et al. Adducin polymorphisms affect renal proximal tubule reabsorption in hypertension. Hypertension 1999; 33:694-697.
7. Torielli L, Tivodar S, Montella RC, Iacone R, Padoani G, Tarsini P, et al. Alpha-adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. Am J Physiol Renal Physiol 2008; 295:F478-F487.
8. Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM, et al. Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertens 2003; 21:1475-1481.
9. Bianchi G, Cusi D. Association and linkage analysis of alpha-adducin polymorphism: is the glass half full or half empty? Am J Hypertens 2001; 13:739-743.
10. Bianchi G, Ferrari P, Staessen J. Adducin polymorphism. Detection and impact on hypertension and related disorders. Hypertension 2005; 45:331-340.
11. Beeks E, Kessels A, Kroon A, van der Klauw M, de Leeuw P. Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens 2004; 22:1243-1249.
12. Grant FD, Romero JR, Jeunematre X, Hunt SC, Hopkins PN, Hollenberg NH, Williams GH. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension 2002; 39:191-196.
13. van Rijn MJ, Schut A, Aulchenko Y, Deinum J, Sayed-Tabatabaei F, Yazdanpanah M, et al. Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes. J Hypertens 2007; 25:565-570.
14. Glorioso N, Filigheddu F, Cusi D, Troffa C, Conti M, Natalizio M, et al. Alpha-adducin 460Trp allele is associated with erythrocyte Na transportrate in North Sardinian primary hypertension. Hypertension 2002; 39:357-362.
15. Morrison AC, Bray MS, Folsom AR, Boerwinkle E. ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension 2002; 39:1053-1057.
16. Psaty BM, Smith NL, Heckbert SR, Vos HL, Lemaitre RN, Reiner AP, et al. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA 2002; 287:1680-1689.
17. Li Y, Thijs L, Kuznetsova T, Zagato L, Struijker-Boudier H, Bianchi G, Staessen J. Cardiovascular risk in relation to alpha-adducin Gly460Trp polymorphism and systolic pressure: a prospective population study. Hypertension 2005; 46:527-532.
18. Zafarmand MH, van der Schouw YT, Grobbee DE, de Leeuw PW, Bots ML. Alpha-adducin Gly460Trp variant increases the risk of stroke in hypertensive Dutch women. Hypertension 2008; 51:1665-1670.
19. Morrison AC, Doris PA, Folsom AR, Nieto FJ, Boerwinkle E. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 2001; 32:822-829.
20. van RijnMJ, BosMJ, YazdanpanahM, Isaacs A, Arias-Vasquez A, Koudstaal PJ, et al. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk. Stroke 2006; 37:2930-2934.
21. van Wieren-de Wijer D, Maitland-van der Zee A-H, de Boer A, Kroon A, de Leeuw P, Schiffers P, et al. Interactions between the Gly460Trp a-adducin gene variant and diuretics and the risk of myocardial infarction. J Hypertens 2008; 27:61-68.
22. Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, Strickler BH. The in?uence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Eur J Hum Genet 2006; 14:860-866.
23. Schelleman H, Klungel OH, Witteman JC, Breteler MM, Hofman A, van Duijn CM, et al. Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics 2007; 7:346-352.
24. Turner ST, Chapman AB, SchwartzGL, Boerwinkle E. Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am J Hypertens 2003; 16:834-839.
25. Glorioso N, Manunta P, Filigheddu F, Troffa C, Stella P, Barlassina C, et al. The role of alpha-adducin polymorphism in blood pressure sodium handling regulation may not be excluded by a negative study. Hypertension 1999; 34:649-654.
26. Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 2003; 41:398-403.
27. Gerhard T, Gong Y, Beitelshees AL, Mao X, Lobmeyer M, Cooper-DeHoff RM, et al. Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES). Am Heart J 2008; 156:397-404.